BioCep's rare cell separation capabilities will allow novel therapy developments such as non-invasive prenatal diagnosis in the 1st trimest
BioCep has developed a novel cell separation technology for rare cell isolation facilitating development of novel clinical applications such as prenatal diagnosis, stem cell therapies and disease management. BioCep will market application-specific systems and consumable kits to customers in these fields. BioCEP will partner with entities to develop these various groundbreaking applications. Sales of BioCEP's R&D cell isolation device has begun.